A Team of Professionals at the Institute of Cancer Research in London has Created a First-of-Its-Kind 3D Model of the Protein Being Targeted by a Novel Drug in Development Designed To Help Kill Cancer Cells
Since 2005, the Institute have discovered twenty drug candidates, eleven of which are in clinical trials today, and five of which are approved by the FDA for use against a range of cancers.